Check-Cap announced that data related to the clinical studies centered on its imaging capsule has been published in Gut, an official journal of the British Society of Gastroenterology.
Here are five insights:
1. The article includes safety and motility data collected in Europe and Israel from an ongoing clinical feasibility study.
2. The study tracked the entire passage of the capsule through the alimentary tract using radio frequency telemetry and Check-Cap's proprietary capsule position tracking system.
3. Pedunculated and sessile polyps were clearly seen and then validated by subsequent colonoscopy. The total radiation exposure was found to be ultra-low.
4. Capsules were excreted naturally in all 48 study volunteers.
5. "These data validate the potential of a less invasive, patient-friendly modality that can screen the colon's interior and provide 3D imaging of the colonic wall without the need for bowel preparation," said Nadir Arber, MD, director of the Integrated Cancer Prevention Center at the Israel Tel Aviv Sourasky Medical Center and scientific advisor to Check-Cap.